Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie R Flaherty

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Metabolites|November 18, 2020
Divergent Impact of Glucose Availability on Human Virus-Specific and Generically Activated CD8 T CellsJenifer Sanchez, Ian Jackson, Katie R Flaherty, et al.
Micropublication Biology|August 22, 2025
Lymphoma-derived extracellular vesicles inhibit CAR T cell functionKhadiza Siddika, Katie R Flaherty, Reuben Benjamin, et al.
Immunotherapy Advances|November 29, 2023
Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key?Katie R Flaherty, Stephanie Kucykowicz, Johannes Schroth, et al.
Cell Reports|July 12, 2025
CAR-T cells containing CD28 versus 4-1BB co-stimulatory domains show distinct metabolic profiles in patientsMolly S Cook, Ellen King, Katie R Flaherty, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Metabolites|November 18, 2020
Divergent Impact of Glucose Availability on Human Virus-Specific and Generically Activated CD8 T CellsJenifer Sanchez, Ian Jackson, Katie R Flaherty, et al.
Micropublication Biology|August 22, 2025
Lymphoma-derived extracellular vesicles inhibit CAR T cell functionKhadiza Siddika, Katie R Flaherty, Reuben Benjamin, et al.
Immunotherapy Advances|November 29, 2023
Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key?Katie R Flaherty, Stephanie Kucykowicz, Johannes Schroth, et al.
Cell Reports|July 12, 2025
CAR-T cells containing CD28 versus 4-1BB co-stimulatory domains show distinct metabolic profiles in patientsMolly S Cook, Ellen King, Katie R Flaherty, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1